Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

US Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedView - Research and Markets

Research and Markets
Posted on: 17 Nov 16

Research and Markets has announced the addition of the "US Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedView" report to their offering.

Diabetes mellitus is a multifaceted disease that yields various approaches in terms of diagnosis, treatment and drug delivery. Products for maintenance and treatment of diabetes can be of high volume and low cost or of relatively low volume and high cost. The U.S. diabetes monitoring, treatment and drug delivery market increased in value in 2016 and growth is expected to persist over the forecast period.

Growth will be driven by the increasing prevalence of diabetes in the U.S. and technological advancements made in certain segments, particularly insulin pumps and continuous glucose monitoring (CGM). Limitations to market growth include pricing pressure due to recent CMS reimbursement changes and the negative impact on the overall blood glucose monitoring market. The recent influx of low-price competitors in the blood glucose test strip segment has also placed downward pressure on prices and resulted in market value contractions despite the growing volume and increasing number of diabetics testing their blood glucose levels.

Key Topics Covered:

Table Of Contents I

List Of Figures Iii

List Of Charts V

Executive Summary

U.S. Diabetes Monitoring, Treatment And Drug Delivery Market Overview

Competitive Analysis

Market Trends

Market Developments

Procedure Numbers

Procedure Codes Investigated

Markets Included

Key Report Updates

Version History

Research Methodology

Companies Mentioned:

Sanofi

Novo Nordisk

Eli Lilly

Medtronic

Johnson & Johnson

Becton Dickinson

Abbott

Roche

DexCom

Ascensia

Insulet

Trividia Health

Tandem

Nova Biomedical

Valeritas

For more information about this report visit http://www.researchandmarkets.com/research/h7sh2w/us_market

View source version on businesswire.com: http://www.businesswire.com/news/home/20161117005617/en/

Business Wire
www.businesswire.com

Last updated on: 17/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.